The third Liver Forum was held on November 12, 2015, in San Francisco, CA.
Materials:
Presentations:
- Liver Forum Welcome, Introduction, and Updates
Veronica Miller, Forum for Collaborative HIV Research - Endpoints and Populations and Trial Designs for Clinical Trials in NASH Indications
Lara Dimick-Santos, U.S. Food and Drug Administration - Regulatory Updates from Europe: Procedures to Promote Early Access of Medicinal Products to the Market
Elmer Schabel, Bundesinstitut für Arzneimittel und Medizinprodukte - An Evolving Partnership Model for Rational Drug Development: Applications to Liver Diseases
Andrew Mulberg, U.S. Food and Drug Administration - Disease Definitions Working Group Progress Report
Stephen Harrison, Brooke Army Medical Center
Sophie Megnien, Genfit - Data Standardization Working Group Progress Report
Andrew Muir, Duke University Medical Center
Joanne Imperial, Fibrogen, Inc. - Non-Invasive Diagnostics: State of the Art
Rohit Loomba, University of California, San Diego - EPoS: Elucidating Pathways of Steatohepatitis (EU)
Quentin Anstee, Newcastle University
